Transmembrane TNF protects mutant mice against intracellular bacterial infections, chronic inflammation and autoimmunity. (Q53598442)

16 May 2018

title

Transmembrane TNF protects mutant mice against intracellular bacterial infections, chronic inflammation and autoimmunity. (English)

1 reference

16 May 2018

main subject

TNF

0 references

inflammation

0 references

transmembrane protein

0 references

1 reference

16 May 2018

Anastasia Kotanidou

1 reference

16 May 2018

Giorgos Kollias

1 reference

16 May 2018

Perry J Blackshear

0 references

Ksanthi Kranidioti

1 reference

16 May 2018

Sofia Xanthoulea

1 reference

16 May 2018

Maria Denis

1 reference

16 May 2018

Eleni Douni

1 reference

16 May 2018

Dimitris L Kontoyiannis

1 reference

16 May 2018

language of work or name

English

0 references

publication date

1 October 2006

1 reference

16 May 2018

European Journal of Immunology

published in

1 reference

16 May 2018

volume

1 reference

16 May 2018

issue

1 reference

16 May 2018

page(s)

2768-2780

1 reference

16 May 2018

Membrane protein secretases

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

Membrane tumor necrosis factor confers partial protection to Listeria infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

An endotoxin-induced serum factor that causes necrosis of tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Identity of tumour necrosis factor and the macrophage-secreted factor cachectin

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

The pathophysiology of tumor necrosis factors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

On the role of tumor necrosis factor and receptors in models of multiorgan failure, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Two tumour necrosis factor receptors: structure and function.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Tumor necrosis factor receptor and Fas signaling mechanisms.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

https://api.crossref.org/works/10.1002%2FEJI.200635921

1 reference

7 January 2021

A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Structural features and biochemical properties of TNF-alpha converting enzyme (TACE).

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

A murine transmembrane tumor necrosis factor (TNF) transgene induces arthritis by cooperative p55/p75 TNF receptor signaling

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

In vivo evidence for a functional role of both tumor necrosis factor (TNF) receptors and transmembrane TNF in experimental hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Complementation of lymphotoxin alpha knockout mice with tumor necrosis factor-expressing transgenes rectifies defective splenic structure and function

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Membrane-bound TNF supports secondary lymphoid organ structure but is subservient to secreted TNF in driving autoimmune inflammation.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Life-threatening histoplasmosis complicating immunotherapy with tumor necrosis factor alpha antagonists infliximab and etanercept

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Listeria monocytogenes infection as a complication of treatment with tumor necrosis factor alpha-neutralizing agents

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Pneumocystis carinii pneumonia following a second infusion of infliximab

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Drug-induced systemic lupus erythematosus associated with etanercept therapy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Tumor necrosis factor antagonist therapy and lymphoma development: twenty-six cases reported to the Food and Drug Administration

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Rapid onset of cutaneous squamous cell carcinoma in patients with rheumatoid arthritis after starting tumor necrosis factor alpha receptor IgG1-Fc fusion complex therapy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Tumor necrosis factor biology in experimental and clinical arthritis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Role of TNF/TNFR in autoimmunity: specific TNF receptor blockade may be advantageous to anti-TNF treatments

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Immune and inflammatory responses in TNF alpha-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune re

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Mixed haplotypes and autoimmunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Accelerated autoimmunity and lupus nephritis in NZB mice with an engineered heterozygous deficiency in tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Uncoupling the proinflammatory from the immunosuppressive properties of tumor necrosis factor (TNF) at the p55 TNF receptor level: implications for pathogenesis and therapy of autoimmune demyelination

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Membrane TNF confers protection to acute mycobacterial infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Generation and Biological Characterization of Membrane-bound, Uncleavable Murine Tumor Necrosis Factor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Processing of tumour necrosis factor-α precursor by metalloproteinases

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Tumor necrosis factor (TNF) receptor type 2 mediates thymocyte proliferation independently of TNF receptor type 1

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Peyer's patch organogenesis is intact yet formation of B lymphocyte follicles is defective in peripheral lymphoid organs of mice deficient for tumor necrosis factor and its 55-kDa receptor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Transmembrane TNF is sufficient to initiate cell migration and granuloma formation and provide acute, but not long-term, control of Mycobacterium tuberculosis infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

A pathogenetic role for TNF alpha in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Roles of tumor necrosis factor-alpha receptor subtypes in the pathogenesis of the tristetraprolin-deficiency syndrome

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Bone marrow transplantation reproduces the tristetraprolin-deficiency syndrome in recombination activating gene-2 (-/-) mice. Evidence that monocyte/macrophage progenitors may be responsible for TNFalpha overproduction

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Critical Points of Tumor Necrosis Factor Action in Central Nervous System Autoimmune Inflammation Defined by Gene Targeting

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

TNF accelerates the onset but does not alter the incidence and severity of myelin basic protein-induced experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Severity of symptoms and demyelination in MOG-induced EAE depends on TNFR1

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Defective CD4T cell priming and resistance to experimental autoimmune encephalomyelitis in TNF-deficient mice due to innate immune hypo-responsiveness

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Impaired On/Off Regulation of TNF Biosynthesis in Mice Lacking TNF AU-Rich Elements

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Anti-cytokine therapeutics and infections

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Induction of unresponsiveness to tumor necrosis factor (TNF) after autocrine TNF expression requires TNF membrane retention.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Development and maturation of secondary lymphoid tissues.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Identification and characterization of 4-[[4-(2-butynyloxy)phenyl]sulfonyl]-N-hydroxy-2,2-dimethyl-(3S)thiomorpholinecarboxamide (TMI-1), a novel dual tumor necrosis factor-alpha-converting enzyme/matrix metalloprotease inhibitor for the treatment o

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

A role for the phagosome in cytokine secretion

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Tumor necrosis factor alpha and lymphotoxin alpha are not required for induction of acute experimental autoimmune encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor alpha

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Deletion of a DNA polymerase beta gene segment in T cells using cell type-specific gene targeting

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Germ-line transmission of genes introduced into cultured pluripotential cells by retroviral vector

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Site-specific recombination of a transgene in fertilized eggs by transient expression of Cre recombinase.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Independent control of immunoglobulin switch recombination at individual switch regions evidenced through Cre-loxP-mediated gene targeting

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635921

7 January 2021

Identifiers

DOI

10.1002/EJI.200635921

1 reference

16 May 2018

1 reference

16 May 2018